Related Experiment Videos
Bit-mapped somatosensory evoked potentials in Down's syndrome individuals
R Ferri1, S Del Gracco, M Elia
1Department of neurology, Oasi Institute for Research on Mental Retardation and Brain Aging (IRCCS), Troina, Italy.
Neurophysiologie Clinique = Clinical Neurophysiology
|November 1, 1994
Summary
Patients with Down's syndrome (DS) exhibit distinct changes in middle-latency somatosensory evoked potentials (MLSEPs). These alterations suggest underlying neurometabolic or neuropathologic differences in individuals with DS.
Area of Science:
- Neuroscience
- Clinical Electrophysiology
Background:
- Down's syndrome (DS) is associated with neurological differences.
- Somatosensory evoked potentials (SEPs) are valuable tools for assessing sensory pathway function.
Purpose of the Study:
- To investigate alterations in middle-latency somatosensory evoked potentials (MLSEPs) in individuals with Down's syndrome.
- To compare MLSEPs in DS patients with age-matched and aged normal controls.
Main Methods:
- Recorded MLSEPs from 19 scalp electrodes in 19 DS patients, 13 age-matched controls, and 11 aged controls.
- Analyzed specific components (P22, N30, P45, N60, P100) and identified novel potentials.
Main Results:
- DS patients showed increased amplitude for P22, N30, P45, and N60 components.
- Significantly shortened P100 latency was observed in DS patients.
- Unique high-voltage negative and positive potentials (100-110 msec) with frontal-central distribution were present in DS subjects, absent in controls.
Conclusions:
- MLSEPs in Down's syndrome patients display characteristic alterations.
- These findings suggest potential underlying neurometabolic and/or neuropathologic variations in DS.
- MLSEPs may serve as a biomarker for neurological differences in Down's syndrome.